SMi's annual conference on Emerging Therapeutic Strategies for Metabolic Disorders will look at the latest preclinical and clinical research in the development of treatments for diabetes and cardiovascular disease. Orphan drugs, anti-inflammatory treatments, and key targets for pharmacological interventions are just some of the topics which will be raised by the expert line-up of industry and academic speakers.

Hear presentations on:

• The therapeutic application of metabolic inhibitors
• The potential of monoclonal antibodies
• AMP-Activated Protein Kinase
• DPP-4 inhibitors and GLP-1 receptor agonists
• Pharmacotherapy for obesity,
• Immune therapy in type I diabetes
• AMP-Activated Protein Kinase as a target in type II diabetes
• Anti-inflammatory and antithromobic strategies to treat atherosclerosis

PLUS a half day pre-conference workshop on the 9th November 2010 Improving Target Selection in Drug Discovery for Metabolic Syndrome Therapies Copthorne Tara Hotel, London, hosted by Thomas Wilckens, Founder, InnVentis